Log in
Enquire now
‌

US Patent 11377456 Crystalline form of Remdesivir

Patent 11377456 was granted and assigned to Apotex on July, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Apotex
Apotex
0
Date Filed
May 25, 2021
0
Date of Patent
July 5, 2022
0
Patent Applicant
Apotex
Apotex
0
Patent Application Number
17601493
0
Patent Citations
‌
US Patent 10065958 Methods and compounds for treating Paramyxoviridae virus infections
‌
US Patent 10675296 Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections
‌
US Patent 10251904 Methods for treating arenaviridae and coronaviridae virus infections
‌
US Patent 10836787 Crystalline forms of (S)-2-ethylbutyl 2-(((S)-(((2R,3S,4R,5R)-5- (4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy) phosphoryl)amino)propanoate
Patent Citations Received
‌
US Patent 12012431 Methods of preparing 1′-cyano nucleosides
0
‌
US Patent 11851438 1′-cyano nucleoside analogs and methods for treatment of viral infections
0
‌
US Patent 11903953 Remdesivir treatment methods
0
‌
US Patent 11926645 Compounds and methods for treatment of viral infections
0
‌
US Patent 11939347 1′-cyano nucleoside analogs and uses thereof
0
‌
US Patent 11975012 Remdesivir treatment methods
0
‌
US Patent 11780844 Compounds and methods for treatment of viral infections
Patent Inventor Names
Fabio E. S. Souza
0
Allan W. Rey
0
Alexander J. Stirk
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11377456
0
Patent Primary Examiner
‌
Traviss C Mcintosh, III
0

Find more entities like US Patent 11377456 Crystalline form of Remdesivir

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.